Nantong Jinghua Pharmaceutical Co Ltd (002349) — Cash Flow Reinvestment Rate
Nantong Jinghua Pharmaceutical Co Ltd (002349) has a Cash Flow Reinvestment Rate of 0.05x as of September 2025, reinvesting CN¥4.62 Million (capex CN¥4.62 Million ) from operating cash flow of CN¥97.93 Million. Explore reinvestment intensity of Nantong Jinghua Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nantong Jinghua Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2025)
Historical reinvestment intensity for Nantong Jinghua Pharmaceutical Co Ltd across 18 annual periods. Also explore total assets of Nantong Jinghua Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
Year-by-year capital reinvestment analysis for Nantong Jinghua Pharmaceutical Co Ltd. For live market cap and broader valuation context, see how much is Nantong Jinghua Pharmaceutical Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | CN¥339.26 Million | CN¥340.87 Million | CN¥20.32 Million | ▲ +18.7% |
| 2024 | 0.84x | CN¥260.87 Million | CN¥311.02 Million | CN¥30.92 Million | ▲ +15.0% |
| 2023 | 0.73x | CN¥212.49 Million | CN¥291.31 Million | CN¥28.38 Million | ▲ +71.2% |
| 2022 | 0.43x | CN¥152.68 Million | CN¥358.39 Million | CN¥61.59 Million | ▲ +53.4% |
| 2021 | 0.28x | CN¥84.87 Million | CN¥305.57 Million | CN¥80.55 Million | ▼ -54.2% |
| 2020 | 0.61x | CN¥198.88 Million | CN¥328.22 Million | CN¥118.46 Million | ▼ -34.0% |
| 2019 | 0.92x | CN¥261.97 Million | CN¥285.38 Million | CN¥255.35 Million | ▼ -52.2% |
| 2018 | 1.92x | CN¥160.33 Million | CN¥83.43 Million | CN¥160.25 Million | ▼ -66.9% |
| 2017 | 5.81x | CN¥441.18 Million | CN¥75.92 Million | CN¥441.17 Million | ▲ +257.2% |
| 2016 | 1.63x | CN¥559.24 Million | CN¥343.80 Million | CN¥245.10 Million | ▲ +157.8% |
| 2014 | 0.63x | CN¥28.83 Million | CN¥45.70 Million | CN¥28.83 Million | ▼ -74.4% |
| 2012 | 2.46x | CN¥190.26 Million | CN¥77.25 Million | CN¥190.26 Million | ▲ +1.2% |
| 2011 | 2.43x | CN¥100.89 Million | CN¥41.45 Million | CN¥100.89 Million | ▲ +178.5% |
| 2010 | 0.87x | CN¥35.89 Million | CN¥41.06 Million | CN¥35.89 Million | ▲ +1046.7% |
| 2009 | 0.08x | CN¥4.40 Million | CN¥57.76 Million | CN¥4.40 Million | ▼ -44.7% |
| 2008 | 0.14x | CN¥2.36 Million | CN¥17.13 Million | CN¥2.36 Million | ▲ +5.1% |
| 2007 | 0.13x | CN¥4.44 Million | CN¥33.86 Million | CN¥4.44 Million | ▼ -1.4% |
| 2006 | 0.13x | CN¥2.95 Million | CN¥22.18 Million | CN¥2.95 Million | — |